Kevin White
About Kevin White
Kevin White serves as the Director of Manufacturing Operations at QuVa Pharma, Inc. in Temple, Texas, a position he has held since 2020, following a notable career at Baxter International Inc.
Work at QuVa Pharma
Kevin White serves as the Director of Manufacturing Operations at QuVa Pharma, Inc. since 2020. His role involves overseeing manufacturing processes and ensuring operational efficiency within the organization. QuVa Pharma is located in Temple, Texas, where White has contributed to the company's mission of providing high-quality sterile compounding services. His leadership in manufacturing operations plays a crucial role in maintaining compliance with industry standards and enhancing production capabilities.
Previous Experience at Baxter International Inc.
Before joining QuVa Pharma, Kevin White held several positions at Baxter International Inc. He worked as Manufacturing Superintendent from 2013 to 2015, where he managed manufacturing operations and staff. Following this role, he served as Director of Manufacturing from 2015 to 2020, focusing on operational leadership and strategic initiatives. Additionally, he briefly worked as Manufacturing Manager I in 2015, gaining valuable experience in production management.
Education and Expertise
Kevin White earned a Bachelor of Business Administration (B.B.A.) degree in Management from Delta State University. His studies spanned from 2010 to 2015, providing him with a solid foundation in business principles and management practices. This educational background supports his expertise in manufacturing operations and leadership roles within the pharmaceutical industry.
Background in Manufacturing and Operations
Kevin White has a diverse background in manufacturing and operations, beginning his career at Robinson Electric as Job Foreman from 2002 to 2005. He then transitioned to Textron Fastening Systems, where he worked as a Lean White Belt from 2005 to 2006, focusing on process improvement methodologies. This early experience laid the groundwork for his subsequent roles in the pharmaceutical sector.